Latest Articles
Ovum Launches with $1.7m Funding to Develop AI-Powered Women’s Health Platform - Femtech Insider
Ovum Launches with $1.7m Funding to Develop AI-Powered Women’s Health Platform Femtech Insider
Published: Aug. 7, 2025, 7:08 a.m.
Will CleanSpark Inc. see short term momentum - Sector Rotation Strategy for Smart Traders - Newser
Will CleanSpark Inc. see short term momentum - Sector Rotation Strategy for Smart Traders Newser
Published: Aug. 7, 2025, 2:03 a.m.
Combining price and volume data for FIGS - High Conviction Stock Long-Term Summary - Newser
Combining price and volume data for FIGS - High Conviction Stock Long-Term Summary Newser
Published: Aug. 7, 2025, 1:09 a.m.
Predictors of Persistent Pain After Hysterectomy for Chronic Pelvic Pain: A Systematic Review.
To systematically review predictors associated with persistent pain after hysterectomy performed for individuals with chronic pelvic pain.
Published: Aug. 7, 2025, midnight
Breaking Down Barriers: Improving Access to Quality Endometriosis Care.
Endometriosis affects an estimated 200 million women globally, yet significant barriers hinder access to timely and appropriate care. These barriers encompass various aspects, including societal normalization of menstrual pain, leading …
Published: Aug. 7, 2025, midnight
Cervical endometriosis mimicking cervical adenocarcinoma: A case report.
Cervical endometriosis is a rare benign condition characterized by ectopic endometrial glands and stroma within the cervix. Its clinical and imaging features resemble those of cervical adenocarcinoma, making preoperative diagnosis …
Published: Aug. 7, 2025, midnight
“Rusty Machete Pain”: Former NC worker files ADA lawsuit over period pain - wfmynews2.com
“Rusty Machete Pain”: Former NC worker files ADA lawsuit over period pain wfmynews2.com
Published: Aug. 6, 2025, 7:43 p.m.
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences The Globe and Mail
Published: Aug. 6, 2025, 1:11 p.m.
Kate's chosen path to single parenting, led by love, strength and determination - The Border Mail
Kate's chosen path to single parenting, led by love, strength and determination The Border Mail
Published: Aug. 6, 2025, 9:01 a.m.
NICE recommends Keytruda for endometrial cancer - The Pharma Letter
NICE recommends Keytruda for endometrial cancer The Pharma Letter
Published: Aug. 6, 2025, 6:49 a.m.
Link copied to clipboard!